发明名称 FUSED IMIDAZOLES FOR CANCER TREATMENT
摘要 Compounds of Formula (I), a tautomer or stereoisomer thereof, or a salt thereof,wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibi tors of the Pi3K/Akt pathway.
申请公布号 WO2009021990(A1) 申请公布日期 2009.02.19
申请号 WO2008EP60686 申请日期 2008.08.14
申请人 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT;HOELDER, SWEN;ZUELCH, ARMIN;BAER, THOMAS;MAIER, THOMAS;ZIMMERMANN, ASTRID;BECKERS, THOMAS;GEKELER, VOLKER;JOSHI, HEMANT;MUNOT, YOGESH;BHISE, UMESH;CHAVAN, SUNIL;SHIVATARE, SACHIN;PATEL, SARVESH;GORE, VIKAS 发明人 HOELDER, SWEN;ZUELCH, ARMIN;BAER, THOMAS;MAIER, THOMAS;ZIMMERMANN, ASTRID;BECKERS, THOMAS;GEKELER, VOLKER;JOSHI, HEMANT;MUNOT, YOGESH;BHISE, UMESH;CHAVAN, SUNIL;SHIVATARE, SACHIN;PATEL, SARVESH;GORE, VIKAS
分类号 C07D471/04;A61K31/437;A61K31/505;A61K31/53;A61P35/00;C07D487/04;C07D498/04;C07D513/04 主分类号 C07D471/04
代理机构 代理人
主权项
地址